Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 392.20
-7.00 (-1.75%)
At close: Dec 31, 2025
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 91.46 billion as of December 31, 2025. Its market cap has increased by 122.80% in one year.
Market Cap
91.46B
Enterprise Value
86.65B
Revenue
1.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
392.20
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 91.46B, an increase of 577.99%. That is a compound annual growth rate of 116.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 268.64B |
| Hansoh Pharmaceutical Group Company | 222.66B |
| JD Health International | 181.32B |
| Innovent Biologics | 136.55B |
| WuXi Biologics | 131.44B |
| Sino Biopharmaceutical | 112.44B |
| Akeso | 102.80B |
| CSPC Pharmaceutical Group | 97.98B |